2011 Fiscal Year Final Research Report
A new therapeutic strategy for tumor induced bone destruction targeting FAK
Project/Area Number |
21689050
|
Research Category |
Grant-in-Aid for Young Scientists (A)
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Okayama University |
Principal Investigator |
SHIMO Tsuyoshi 岡山大学, 大学院・医歯薬学総合研究科, 助教 (40362991)
|
Project Period (FY) |
2009 – 2011
|
Keywords | FAK / 破骨細胞 / 癌骨浸潤 |
Research Abstract |
Focal adhesion kinase(FAK) is a 125-kDa non-receptor type tyrosine kinase that localizes to focal adhesions. FAK overexpression is frequently found in invasive and metastatic cancers, but its role in osteolytic metastasis is not well understood. In this study, we have analyzed anti-tumor effects of the FAK against bone metastasis in cancer, we found that FAK was critically involved in osteolytic metastasis and activated in tumors, pre-osteoclasts, and mature osteoclasts. These results suggest that FAK can be effective target for the treatment of cancer induced bone metastasis.
|
-
[Journal Article] Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma2012
Author(s)
Naito Kurio, Tsuyoshi Shimo, Takuya Fukazawa, Tatsuo Okui, Nur Mohammad Monsur Hassan, Tatsuki Honami, Yuu Horikiri, Shinji Hatakeyama, Munenori Takaoka, Yoshio Naomoto, Akira Sasaki
-
Journal Title
Oral Oncology
Volume: (accepted)
Peer Reviewed
-
[Journal Article] Effect of a novel FAK inhibitor TAE226 on the breast cancer associated with bone metastasis2011
Author(s)
Naito Kurio, Tsuyoshi Shimo, Takuya Fukazawa, Munenori Takaoka, Tatsuo Okui, Nur Mohammad Monsur Hassan, Tatsuki Honami, Shinji Hatakeyama, Masahiko Ikeda, Yoshio Naomoto, Akira Sasaki
-
Journal Title
Experimental Cell Research
Volume: 317(8)
Pages: 1134-1146
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-